Salient Bio
Salient Bio develops non-invasive diagnostic tests that detect hard-to-identify conditions such as Crohn’s disease and ulcerative colitis using microbiome signals. The company combines metagenomic sequencing of gut, oral, and vaginal microbiomes with machine learning and comprehensive bioinformatic analysis to generate diagnostic and wellness insights. It operates an ISO 17025–certified laboratory and offers classical blood and stool diagnostic tests alongside its microbiome services. Salient Bio positions itself as a B2B SaaS/lab services provider to clinical and reference labs while also offering wellness-facing tests. Its platform targets clinical diagnostics and consumer wellness markets that require high-throughput sequencing, bioinformatics, and regulated lab operations.
Salient Bio
Salient Bio develops non-invasive diagnostic tests that detect hard-to-identify conditions such as Crohn’s disease and ulcerative colitis using microbiome signals. The company combines metagenomic sequencing of gut, oral, and vaginal microbiomes with machine learning and comprehensive bioinformatic analysis to generate diagnostic and wellness insights. It operates an ISO 17025–certified laboratory and offers classical blood and stool diagnostic tests alongside its microbiome services. Salient Bio positions itself as a B2B SaaS/lab services provider to clinical and reference labs while also offering wellness-facing tests. Its platform targets clinical diagnostics and consumer wellness markets that require high-throughput sequencing, bioinformatics, and regulated lab operations.